For many patients with terminal/advanced cardiac failure, heart transplantation is the most
effective, durable treatment option, and offers the best prospects for a high quality of life. The …

Heart transplantation is advocated in selected patients with advanced heart failure in the
absence of contraindications. Principal challenges in heart transplantation centre around an …

Background A shortage of donation after brain death (DBD) donors for heart transplantation
(HT) persists. Recent improvements in organ procurement from donation after circulatory …

Heart transplantation from donation after circulatory death (DCD) donors has the potential to
substantially increase overall heart transplant activity. The aim of this report is to review the …

Approximately 65 million adults globally have heart failure, and the prevalence is expected
to increase substantially with ageing populations. Despite advances in pharmacological and …

The first human heart transplantation was performed by Christian Barnard in 1967. While the
technical aspect had been worked out, allograft rejection was a major limitation in the early …

Heart transplantation remains the gold-standard therapy for end-stage heart failure; the
expected median survival range is 12–13 years. More than 30,000 heart transplants have …

The effect of using donation after circulatory death (DCD) hearts on waitlist outcomes has
not been substantiated. We retrospectively analyzed 184 heart transplant (HT) candidates at …

Objective. Adopting hearts from donation after circulatory death (DCD) is a promising
approach to enlarge the donor pool. Nevertheless, DCD hearts experience severe warm …

Donation after circulatory death (DCD) could account for the largest expansion of the donor
allograft pool in the contemporary era. However, the organ yield and associated costs of …